Zenith® Fenestrated+ Clinical Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 105 participants.
Also called NCT04875429
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 105 participants
- Sponsor
- Registry
-
NCT04875429
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT04875429. Allocation not applicable; no masking; primary purpose treatment. Start 2023-12-08 (actual); primary completion 2026-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Zenith® Fenestrated+ Clinical Study
- Condition
- Aortic Aneurysm, Abdominal
- Condition
- Juxtarenal Aortic Aneurysm
- Condition
- Extent IV Thoracoabdominal
- Condition
- Pararenal Aneurysm
- Intervention (Device)
- Zenith Fenestrated+ Endovascular Graft in combination with the BeGraft Balloon-Expandable FEVAR Bridging Stent Graft System and Unibody2
- Lead sponsor
- Cook Research Incorporated
Record details
- Record id
cardio:ct-nct04875429- Content hash
0fb9a758fe2e4cfdb4ecb2527a47fc3f306125e6ecb0be279b766dfe61e27324